Patent Assignment
Reel/Frame 050982/0751
Assignment of Assignor's Interest
Recorded: 2019-11-12
Pages: 4
Assignor
BERRY, DAVID A.
Executed: 2014-11-12
Assignee
FLAGSHIP VENTURES MANAGEMENT, INC.
1 MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(8)
Erythroid Cells Comprising Thymidine Phosphorylase
Application:
16/409,573 →
Publication:
US 2019/0264177
Erythroid Cells Comprising Phenylalanine Ammonia Lyase
Erythroid Cells Comprising Arginine Deiminase
Application:
16/426,880 →
Publication:
US 2019/0316090
Erythroid Cells Comprising Arginase
Application:
16/426,905 →
Publication:
US 2019/0316091
Erythroid Cells Comprising Lysine Oxidase
Application:
16/431,236 →
Publication:
US 2019/0309261
Erythroid Cells Comprising Serine Dehydratase
Application:
16/431,270 →
Publication:
US 2019/0309262
Platelets Comprising Exogenous Polypeptides and Uses Thereof
Application:
16/549,840 →
Publication:
US 2019/0376034
Erythroid Cells Comprising Phenylalanine Hydroxylase
Application:
16/572,129 →
Publication:
US 2020/0002674
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 12, 2019
From: KAHVEJIAN, AVAK; MATA-FINK, JORDI; ROUND, JOHN; AFEYAN, NOUBAR B.
To: FLAGSHIP VENTURES MANAGEMENT, INC.
Reel/Frame 050982/0743 →
Assignment of Assignor's Interest
Nov 12, 2019
From: FLAGSHIP VENTURES MANAGEMENT, INC.
To: VL26, INC.
Reel/Frame 050982/0767 →
Change of Name
Nov 12, 2019
From: VL26, INC.
To: RUBIUS THERAPEUTICS, INC.
Reel/Frame 050990/0602 →